Genetic Technologies Limited
GNTLF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $10 | $10 | $9 | $1 |
| % Growth | -6.5% | 12.3% | 590.6% | – |
| Cost of Goods Sold | $4 | $4 | $0 | $0 |
| Gross Profit | $4 | $6 | $6 | -$0 |
| % Margin | 40.4% | 58.1% | 70.2% | -18% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $10 | $9 | $2 | $4 |
| SG&A Expenses | $13 | $12 | $10 | $6 |
| Sales & Mktg Exp. | $3 | $3 | $2 | $0 |
| Other Operating Expenses | -$1 | -$1 | $0 | $0 |
| Operating Expenses | $12 | $12 | $11 | $7 |
| Operating Income | -$12 | -$6 | -$5 | -$6 |
| % Margin | -126.2% | -58.6% | -52.2% | -434.5% |
| Other Income/Exp. Net | $0 | -$6 | -$2 | -$1 |
| Pre-Tax Income | -$12 | -$12 | -$7 | -$7 |
| Tax Expense | $0 | -$0 | -$0 | $0 |
| Net Income | -$12 | -$12 | -$7 | -$7 |
| % Margin | -124.2% | -113.6% | -77.4% | -530.3% |
| EPS | -0.091 | -0.12 | -0.077 | -0.083 |
| % Growth | 24.3% | -55.2% | 6.6% | – |
| EPS Diluted | -0.091 | -0.12 | -0.077 | -0.083 |
| Weighted Avg Shares Out | 138 | 101 | 92 | 85 |
| Weighted Avg Shares Out Dil | 138 | 101 | 92 | 85 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$11 | -$11 | -$7 | -$7 |
| % Margin | -118.2% | -108.3% | -78.1% | -536.1% |